Pediatrics Doctors in Bladensburg, MD - Medicare Status, Address, Contact

1 Pediatrics doctors found. Showing 1 - 1

Shaaron Rose Towns, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 5632 Annapolis Rd, Ste 7, Bladensburg, MD 20710
Phone: 301-927-2490 Fax: 301-927-6587

News Archive

FDA fast tracks HIV protease inhibitor from Vertex and GSK

Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.

LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar for psoriasis treatment

LEO Pharma A/S today announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch relief and improvements in itch-related sleep loss for patients suffering from psoriasis.

Scientists investigate factors that influence social stigma of mental illness

How dangerous does the general public consider mentally ill people to be? Scientists at the University of Basel and the University Psychiatric Clinics Basel have investigated the factors that influence social stigma. The journal Scientific Reports published the results.

OrSense launches a non-invasive Hb measurement system for anemia screening

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today at the American Association of Blood Banks (AABB) Annual Meeting & TXPO, at New Orleans, the presentation of NBM-200, a non-invasive hemoglobin (Hb) measurement system for anemia screening in blood donation centers.

Helsinn to present Phase III trial data of anamorelin at ESMO Congress

Helsinn Group, a company focused on building quality cancer care, today announces that Phase III data from the largest trial program of its kind to date in anamorelin, a novel, once-daily ghrelin receptor agonist in development for cancer-anorexia-cachexia (CACS) in non-small cell lung cancer will be presented at the 38th European Society for Medical Oncology Congress in Madrid, Spain, in 2014.

Pediatrics Doctors in Bladensburg, MD Accepting Medicare